Form 4: Clorox Director Spencer C. Fleischer Reports Acquisition of Deferred Stock Units

Sentiment:

SEC Form 4 Filing


Director Spencer C. Fleischer reports acquisition of Clorox deferred stock units through dividend reinvestment and in lieu of quarterly director's fees.

Summary

  • On March 28, 2024, Spencer C. Fleischer, a director of Clorox Co, acquired 204.1016 deferred stock units in lieu of quarterly director's fees.
  • These units will be settled in Clorox stock upon the director's retirement or termination of service.
  • Additionally, on February 9, 2024, Fleischer acquired 119.9773 deferred stock units through dividend reinvestment.
  • Following these transactions, Fleischer beneficially owns 15,641.1779 deferred stock units.
  • The price for both transactions was $0.0000.

Sentiment

Score: 7

Explanation: The sentiment is neutral to positive. The director's acquisition of stock units suggests confidence in the company's future, but it's a routine transaction.

Positives

  • The acquisition of deferred stock units by a director signals confidence in the company's future performance.

Future Outlook

The deferred stock units will be settled 100% in Clorox stock upon the director's retirement or other termination of service.

Industry Context

Director stock acquisitions are common and are viewed as a sign of confidence in the company's future. These transactions are routinely disclosed to the SEC.

Comparison to Industry Standards

  • Director compensation packages often include deferred stock units as a way to align the interests of management with those of shareholders.
  • Companies like Procter & Gamble (PG) and Unilever (UL) also use similar compensation strategies for their directors.
  • The amount of deferred stock units granted is generally in line with industry standards for director compensation at companies of similar size and market capitalization.

Stakeholder Impact

  • The acquisition of deferred stock units by a director can positively influence shareholder sentiment.

Key Dates

DateDescription
02/09/2024Acquisition of 119.9773 Deferred Stock Units through dividend reinvestment.
03/28/2024Acquisition of 204.1016 Deferred Stock Units in lieu of quarterly director's fees.
04/02/2024Date of signature for the Form 4 filing.

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.